advocacy in action: who should have molecular testing when diagnosed with lung cancer?
Published 11 years ago • 137 plays • Length 9:47Download video MP4
Download video MP3
Similar videos
-
5:42
advocacy in action: what should patients expect when getting molecular testing?
-
9:22
advocacy in action: understanding biomarker testing for lung cancer
-
8:02
advocacy in action: the role of advocates in patient education for biomarker testing
-
5:29
advocacy in action: what if molecular testing is not offered?
-
8:27
advocacy in action: where to get molecular tumor testing?
-
17:43
how biomarker testing gave me better lung cancer treatment options | shyreece’s story (2 of 4)
-
7:04
what if a simple blood test could detect cancer? | hani goodarzi | ted
-
11:52
lung cancer patient stories: clinical trials (& patient self-advocacy!) | shyreece’s story (3 of 4)
-
7:11
advocacy in action: national lung cancer partnership
-
13:52
advocacy in action: disparities & inequities in cancer care
-
4:05
advocacy in action: what if a patient is told they have no tumor marker?
-
11:12
advocacy in action: role of global advocate community in research & clinical trials
-
11:51
advocacy in action: the urgency of tissue collection for cancer research
-
8:54
advocacy in action: the issue is the tissue
-
13:09
advocacy in action: international perspectives in cancer patient advocacy
-
6:00
advocacy in action: what are the greatest obstacles to tissue collection
-
3:56
key next steps after a lung cancer diagnosis: expert advice
-
16:14
advocacy in action esmo 2012: personalized medicine and pathology
-
6:04
advocacy in action: communicating with patients about tissue collection
-
8:25
advocacy in action: jill's legacy
-
4:27
advocacy in action: cara tenenbaum - ovarian cancer national alliance